Myriad Genetics, Inc. Receives Approval From New York Stock Exchange to Proceed With New Listing

SALT LAKE CITY, UT--(Marketwire - December 16, 2008) - Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that the NYSE's Listing and Compliance Committee has received Myriad's eligibility materials and cleared it to file an application to transfer trading of Myriad's shares to the New York Stock Exchange ("NYSE") from NASDAQ. Myriad Genetics anticipates trading on the NYSE Big Board in the second calendar quarter of 2009. Upon transfer the stock will trade under the new ticker symbol "MGX."